1. Home
  2. MLAB vs MYD Comparison

MLAB vs MYD Comparison

Compare MLAB & MYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • MYD
  • Stock Information
  • Founded
  • MLAB 1982
  • MYD 1991
  • Country
  • MLAB United States
  • MYD United States
  • Employees
  • MLAB N/A
  • MYD N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • MYD Investment Bankers/Brokers/Service
  • Sector
  • MLAB Industrials
  • MYD Finance
  • Exchange
  • MLAB Nasdaq
  • MYD Nasdaq
  • Market Cap
  • MLAB 441.2M
  • MYD 460.1M
  • IPO Year
  • MLAB N/A
  • MYD N/A
  • Fundamental
  • Price
  • MLAB $73.67
  • MYD $10.56
  • Analyst Decision
  • MLAB Hold
  • MYD
  • Analyst Count
  • MLAB 1
  • MYD 0
  • Target Price
  • MLAB $67.00
  • MYD N/A
  • AVG Volume (30 Days)
  • MLAB 100.5K
  • MYD 253.1K
  • Earning Date
  • MLAB 11-06-2025
  • MYD 01-01-0001
  • Dividend Yield
  • MLAB 0.87%
  • MYD 4.55%
  • EPS Growth
  • MLAB N/A
  • MYD N/A
  • EPS
  • MLAB N/A
  • MYD N/A
  • Revenue
  • MLAB $245,255,000.00
  • MYD N/A
  • Revenue This Year
  • MLAB $5.38
  • MYD N/A
  • Revenue Next Year
  • MLAB $5.25
  • MYD N/A
  • P/E Ratio
  • MLAB N/A
  • MYD N/A
  • Revenue Growth
  • MLAB 7.39
  • MYD N/A
  • 52 Week Low
  • MLAB $55.45
  • MYD $8.76
  • 52 Week High
  • MLAB $155.12
  • MYD $11.30
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 46.86
  • MYD 46.07
  • Support Level
  • MLAB $70.00
  • MYD $10.51
  • Resistance Level
  • MLAB $82.37
  • MYD $10.67
  • Average True Range (ATR)
  • MLAB 4.39
  • MYD 0.08
  • MACD
  • MLAB -0.25
  • MYD -0.01
  • Stochastic Oscillator
  • MLAB 29.18
  • MYD 23.53

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About MYD Blackrock MuniYield Fund Inc.

Blackrock Muniyield Fund Inc is a non-diversified, closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.

Share on Social Networks: